Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Male hormones may increase the severity and death rates of COVID-19.

Regular mole checks and UV protection are crucial, especially for fair-skinned and health-compromised individuals.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

Most people in South India lack knowledge about managing COVID-19 at home.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Training programs are needed to improve home COVID-19 management practices.

Public interest in hair loss increased during the COVID-19 pandemic.

A patient with Ehlers-Danlos Syndrome improved after treatment for fat malabsorption and essential fatty acid deficiency.

A combination of arginine silicate complex and magnesium biotinate improves hair and nail growth in rats.

S-equol supplements significantly reduced menopausal symptoms in most women.

Contract cheating website traffic in Spain surged during COVID-19 but declined with the rise of AI tools.

Both oral and topical minoxidil effectively regrow hair in men with similar results.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Expanding telemedicine in Japan reduced healthcare costs without harming health outcomes.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Severe hair loss may increase the risk of dying from COVID-19.

Hair loss was the most common skin issue among healthcare workers with COVID-19.

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.

Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.